Page last updated: 2024-11-05

n-methylpyrrole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

N-methylpyrrole is a heterocyclic aromatic compound with the molecular formula C5H7N. It is a colorless liquid with a characteristic odor. N-methylpyrrole is a common building block in organic synthesis and is used in the preparation of various pharmaceuticals, agrochemicals, and other fine chemicals. It is also found in natural products, such as chlorophyll and heme. N-methylpyrrole is a relatively stable compound and can be synthesized by various methods, including the reaction of pyrrole with methyl iodide. It has been studied for its potential use in the development of new drugs and materials. For example, N-methylpyrrole derivatives have shown promising activity as anti-cancer agents. In addition, N-methylpyrrole-based polymers have been investigated for their potential use as electronic materials. N-methylpyrrole is a versatile compound with a wide range of applications. It is a valuable reagent in organic synthesis and has potential applications in the development of new drugs and materials.'

Cross-References

ID SourceID
PubMed CID7304
CHEMBL ID1234459
CHEBI ID89012
MeSH IDM0254223

Synonyms (47)

Synonym
methylpyrrole
nsc 65440
einecs 202-513-7
ccris 2934
chebi:89012 ,
CHEMBL1234459
1-methylpyrrole
pyrrole, 1-methyl-
nsc65440
nsc-65440
n-methylpyrrole
1h-pyrrole, 1-methyl-
inchi=1/c5h7n/c1-6-4-2-3-5-6/h2-5h,1h
1-methyl-1h-pyrrole ,
96-54-8
1-methylpyrrole, >=99%
n-methylpyrrole, 99%
mr3 ,
M0414
AKOS000120156
unii-ng5gpn98zg
ng5gpn98zg ,
n-methyl pyrrole
FT-0672131
FT-0608093
2-[4-(4-methoxybenzoyl)piperazin-1-yl]-1-morpholino-ethanone
n-methyl-pyrrole
n-methylpyrrol
1-methylpyrrol
tox21_303918
dtxcid4031221
dtxsid3052648 ,
NCGC00357166-01
cas-96-54-8
W-100140
F0001-2301
CS-W001239
mfcd00005345
1-methylpyrrole, analytical standard
D78235
1-methyl-pyrrole
Z57127895
Q27161153
AM10659
STL183826
SB62083
EN300-17950
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyrrolesAn azole that includes only one N atom and no other heteroatom as a part of the aromatic skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency54.48270.006038.004119,952.5996AID1159521
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency76.95880.001530.607315,848.9004AID1224841
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (63)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.59)18.7374
1990's6 (9.52)18.2507
2000's37 (58.73)29.6817
2010's15 (23.81)24.3611
2020's4 (6.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.36 (24.57)
Research Supply Index4.16 (2.92)
Research Growth Index5.52 (4.65)
Search Engine Demand Index46.01 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (6.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other59 (93.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]